e-Drug3D

2196

M ELINZANETANT

INN
ELINZANETANT

cas 3055971-16-6

CLASS

GENITO
NEUROKININ 1 (NK1) AND NEUROKININ 3 (NK3) RECEPTOR ANTAGONIST
TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE

ROUTE (list)

ATC code

G02CX07

PK parameters

Tmax 2 HOUR (PMID39719488)
t1/2 31.3 HOUR (PMID39719488)

Target

TARGET NEUROKININ 1 (NK1)
NEUROKININ 3 (NK3)

DrugCentral

Download SDF file

Benzeneacetamide, N-[4-[4-fluoro-2-(hydroxymethyl)phenyl]-6-[(7S,9aS)-hexahydro-3-hydroxy-7-(hydroxymethyl)pyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl]-N,alpha,alpha-trimethyl-3,5-bis(trifluoromethyl)- (ACI)

Formula:
C33H35F7N4O5

Calculated chemical properties:

MW 700.65
NB_atoms 49
XLogP 4.56
PSA 106.248
NB_HD 3
NB_HA 9
fsp3 0.45
Lipinski(0=no;1=yes) 0

FDA
-